Germany brought in a record-setting 41 tons of medical marijuana in the first quarter of 2025, according to new data from the Federal Institute for Drugs and Medical Devices (BfArM).
That figure marks a massive jump from the same period last year, when the country imported under 9 tons—making this year’s total nearly 4.6 times higher.
The majority of the imports, roughly 17.7 tons, came from Canada, a long-standing supplier of medical cannabis to international markets.
Niklas Kouparanis, CEO and co-founder of Bloomwell Group, says Germany is on pace to import 150 tons of medical and scientific cannabis products by year’s end. “The German model thus serves as a model for the entire EU,” said Kouparanis, pointing to the ease of patient access and the country’s digital infrastructure. “It shows how to successfully transform an illegal patient care system into a legal one at scale.”
Germany is widely seen as the largest medical marijuana market in Europe, due in part to its relatively low barriers for obtaining prescriptions.
The surge in imports comes just over a year after the country legalized marijuana possession and personal cultivation for adults. That law, which took effect in February 2024, allows individuals to carry up to 25 grams of marijuana and grow up to three plants per household. It also created a framework for nonprofit cannabis cultivation clubs to distribute marijuana to their members.
Germany’s recent shift in government leadership doesn’t appear likely to reverse course on the issue. Following February’s election, Chancellor Friedrich Merz and a coalition of conservative and center-left parties formed a new government in April, but early indications suggest they will leave the country’s cannabis reforms largely intact.
